0001832728-20-000001.txt : 20201117
0001832728-20-000001.hdr.sgml : 20201117
20201117171407
ACCESSION NUMBER: 0001832728-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
EFFECTIVENESS DATE: 20201117
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apertor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001832728
IRS NUMBER: 853493161
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-380841
FILM NUMBER: 201322004
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: (857) 352-3657
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
D
1
primary_doc.xml
X0708
D
LIVE
0001832728
Apertor Pharmaceuticals, Inc.
230 PARK AVENUE
SUITE 2800
NEW YORK
NY
NEW YORK
10169
(857) 352-3657
DELAWARE
None
None
Corporation
true
2020
Spiros
Liras
c/o Apertor Pharmaceuticals, Inc.
230 Park Avenue, Suite 2800
New York
NY
NEW YORK
10169
Executive Officer
Director
Seth
Harrison
c/o Apertor Pharmaceuticals, Inc.
230 Park Avenue, Suite 2800
New York
NY
NEW YORK
10169
Director
Paul
Eisenberg
c/o Apertor Pharmaceuticals, Inc.
230 Park Avenue, Suite 2800
New York
NY
NEW YORK
10169
Director
Edmund
Graziani
c/o Apertor Pharmaceuticals, Inc.
230 Park Avenue, Suite 2800
New York
NY
NEW YORK
10169
Executive Officer
Director
Robert
T.
Abraham
c/o Apertor Pharmaceuticals, Inc.
230 Park Avenue, Suite 2800
New York
NY
NEW YORK
10169
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-11-05
false
true
false
0
50000000
3000000
47000000
false
1
0
0
0
false
Apertor Pharmaceuticals, Inc.
/s/ Spiros Liras
Spiros Liras
President
2020-11-17